- Home
- TRT vs ATHA Comparison
TRT vs ATHA Comparison
Compare TRT & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- ATHA
- Stock Information
- Founded
- TRT 1958
- ATHA 2011
- Country
- TRT United States
- ATHA United States
- Employees
- TRT N/A
- ATHA N/A
- Industry
- TRT Industrial Machinery/Components
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- TRT Technology
- ATHA Health Care
- Exchange
- TRT Nasdaq
- ATHA Nasdaq
- Market Cap
- TRT 25.2M
- ATHA 21.0M
- IPO Year
- TRT N/A
- ATHA 2020
- Fundamental
- Price
- TRT $6.10
- ATHA $0.34
- Analyst Decision
- TRT
- ATHA Buy
- Analyst Count
- TRT 0
- ATHA 4
- Target Price
- TRT N/A
- ATHA $11.25
- AVG Volume (30 Days)
- TRT 5.9K
- ATHA 179.5K
- Earning Date
- TRT 02-13-2025
- ATHA 02-27-2025
- Dividend Yield
- TRT N/A
- ATHA N/A
- EPS Growth
- TRT N/A
- ATHA N/A
- EPS
- TRT 0.13
- ATHA N/A
- Revenue
- TRT $38,562,000.00
- ATHA N/A
- Revenue This Year
- TRT N/A
- ATHA N/A
- Revenue Next Year
- TRT N/A
- ATHA N/A
- P/E Ratio
- TRT $46.70
- ATHA N/A
- Revenue Growth
- TRT N/A
- ATHA N/A
- 52 Week Low
- TRT $5.22
- ATHA $0.34
- 52 Week High
- TRT $7.88
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- TRT 52.08
- ATHA 28.43
- Support Level
- TRT $5.80
- ATHA $0.34
- Resistance Level
- TRT $6.40
- ATHA $0.40
- Average True Range (ATR)
- TRT 0.23
- ATHA 0.04
- MACD
- TRT 0.02
- ATHA -0.01
- Stochastic Oscillator
- TRT 64.29
- ATHA 2.30
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.